H2020FP7HORIZON
Academisch Ziekenhuis Leiden
- Country
- NLNetherlands
- Defence projects
- 0
- Projects, all programmes
- 336
- As coordinator
- 102
- EU contribution (CORDIS)
- EUR 216,538,375
- Active
- 2008 to 2026
Projects
336 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| SIMICASite-selective protein-modification chemistries for antibody-drug conjugates (ADCs) | H2020 | 2019 | Participant | EUR 35,000 |
| HarmonizATformsDefining the antithrombin measurand: role of proteoforms in harmonisation of diagnostic tests in thrombosis | H2020 | 2019 | Coordinator | EUR 187,572 |
| RARITYRAtional design of canceR ImmunoTherapY: one size does not fit all | H2020 | 2019 | Coordinator | EUR 1,499,795 |
| DiurnalHealthThe circadian clock in day-active species: preserving our health in modern society | H2020 | 2019 | Coordinator | EUR 2,166,756 |
| iPSpineInduced pluripotent stem cell-based therapy for spinal regeneration | H2020 | 2019 | Participant | EUR 219,148 |
| MICROB-PREDICTMICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response | H2020 | 2019 | Participant | EUR 500,500 |
| RespiriTBProgress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors | H2020 | 2019 | Coordinator | EUR 1,074,533 |
| FAIRsFAIRFostering FAIR Data Practices in Europe | H2020 | 2019 | Third party | Not stated |
| EOSC-LifeProviding an open collaborative space for digital biology in Europe | H2020 | 2019 | Participant | EUR 112,500 |
| VASAVaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa | H2020 | 2019 | Participant | EUR 612,856 |
| PAVEA nanovaccine Approach for the treatment of Pancreatic Cancer | H2020 | 2019 | Participant | EUR 531,240 |
| RespiriNTMProgress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline | H2020 | 2019 | Coordinator | EUR 1,389,368 |
| PHOOTONICSA Cost-Effective Photonics-based Device for Early Prediction, Monitoring and Management of Diabetic Foot Ulcers | H2020 | 2019 | Participant | EUR 149,375 |
| INITIATEINnate-ImmunomeTabolIsm as Antiviral TargEt | H2020 | 2019 | Participant | EUR 531,240 |
| TAcTICTArgeTed molecular Imaging and surgery for gastro-intestinal Cancer | H2020 | 2019 | Coordinator | EUR 128,750 |
| EU-OPENSCREEN-DRIVEEnsuring long-term sustainability of excellence in chemical biology within Europe and beyond | H2020 | 2019 | Participant | EUR 22,555 |
| EJP RDEuropean Joint Programme on Rare Diseases | H2020 | 2019 | Participant | EUR 1,962,613 |
| imSAVARImmune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies | H2020 | 2019 | Participant | EUR 412,973 |
| ArthritisHealEstablishing the molecular fundamentals of arthritic diseases – a step forward to Heal Arthritis | H2020 | 2019 | Coordinator | EUR 796,860 |
| CANCERPersonalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life | H2020 | 2018 | Participant | EUR 162,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.